{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:25:54Z","timestamp":1791555954793,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11892-015-0581-x","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T11:42:17Z","timestamp":1422877337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hyperglycemia in Patients with Hematologic Malignancies"],"prefix":"10.1007","volume":"15","author":[{"given":"Sara J.","family":"Healy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Dungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"581_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.","edition":"4"},{"issue":"19","key":"581_CR2","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","volume":"116","author":"M Sant","year":"2010","unstructured":"Sant M et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724\u201334.","journal-title":"Blood"},{"issue":"17","key":"581_CR3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813\u201326.","journal-title":"N Engl J Med"},{"key":"581_CR4","unstructured":"Blood cancer facts 2013 Flyer; Available from: http:\/\/www.lls.org\/#\/resourcecenter\/freeeducationmaterials\/generalcancer\/ (2014)."},{"key":"581_CR5","unstructured":"Cancer facts & figures 2014; Available from: http:\/\/www.cancer.org\/research\/cancerfactsstatistics\/cancerfactsfigures2014\/index (2014)."},{"issue":"4","key":"581_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4158\/EP10027.RA","volume":"16","author":"ML Griffith","year":"2010","unstructured":"Griffith ML, Jagasia M, Jagasia SM. Diabetes mellitus after hematopoietic stem cell transplantation. Endocr Pract. 2010;16(4):699\u2013706.","journal-title":"Endocr Pract"},{"issue":"18","key":"581_CR7","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMcp060094","volume":"355","author":"SE Inzucchi","year":"2006","unstructured":"Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903\u201311.","journal-title":"N Engl J Med"},{"issue":"1","key":"581_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10753-012-9533-7","volume":"36","author":"E Gebremedhin","year":"2013","unstructured":"Gebremedhin E et al. Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease. Inflammation. 2013;36(1):177\u201385. This prospective study found a relationship between severe hyperglycemia and GVHD among normal-to-overweight subjects.","journal-title":"Inflammation"},{"issue":"14","key":"581_CR9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM199304083281409","volume":"328","author":"JO Armitage","year":"1993","unstructured":"Armitage JO. Treatment of non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;328(14):1023\u201330.","journal-title":"N Engl J Med"},{"issue":"2","key":"581_CR10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166\u201378.","journal-title":"N Engl J Med"},{"issue":"19","key":"581_CR11","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1200\/JCO.2000.18.19.3409","volume":"18","author":"JP Ioannidis","year":"2000","unstructured":"Ioannidis JP, Hesketh PJ, Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol. 2000;18(19):3409\u201322.","journal-title":"J Clin Oncol"},{"issue":"5","key":"581_CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4158\/EP08331.RAR","volume":"15","author":"JN Clore","year":"2009","unstructured":"Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469\u201374.","journal-title":"Endocr Pract"},{"issue":"1","key":"581_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jcem-54-1-131","volume":"54","author":"RA Rizza","year":"1982","unstructured":"Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab. 1982;54(1):131\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"581_CR14","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI111141","volume":"72","author":"G Pagano","year":"1983","unstructured":"Pagano G et al. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 1983;72(5):1814\u201320.","journal-title":"J Clin Invest"},{"issue":"4","key":"581_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diab.44.4.441","volume":"44","author":"SP Weinstein","year":"1995","unstructured":"Weinstein SP et al. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes. 1995;44(4):441\u20135.","journal-title":"Diabetes"},{"issue":"10","key":"581_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0028-1092779","volume":"11","author":"B Billaudel","year":"1979","unstructured":"Billaudel B, Sutter BC. Direct effect of corticosterone upon insulin secretion studied by three different techniques. Horm Metab Res. 1979;11(10):555\u201360.","journal-title":"Horm Metab Res"},{"issue":"2","key":"581_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/endo-106-2-547","volume":"106","author":"G Barseghian","year":"1980","unstructured":"Barseghian G, Levine R. Effect of corticosterone on insulin and glucagon secretion by the isolated perfused rat pancreas. Endocrinology. 1980;106(2):547\u201352.","journal-title":"Endocrinology"},{"issue":"5","key":"581_CR18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1210\/endo-111-5-1648","volume":"111","author":"G Barseghian","year":"1982","unstructured":"Barseghian G, Levine R, Epps P. Direct effect of cortisol and cortisone on insulin and glucagon secretion. Endocrinology. 1982;111(5):1648\u201351.","journal-title":"Endocrinology"},{"issue":"2","key":"581_CR19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1677\/joe.0.1000227","volume":"100","author":"B Billaudel","year":"1984","unstructured":"Billaudel B et al. Inhibition by corticosterone of calcium inflow and insulin release in rat pancreatic islets. J Endocrinol. 1984;100(2):227\u201333.","journal-title":"J Endocrinol"},{"issue":"3","key":"581_CR20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","volume":"99","author":"C Lambillotte","year":"1997","unstructured":"Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest. 1997;99(3):414\u201323.","journal-title":"J Clin Invest"},{"issue":"7","key":"581_CR21","first-page":"2621","volume":"81","author":"K Matsumoto","year":"1996","unstructured":"Matsumoto K et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab. 1996;81(7):2621\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"581_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOH.0b013e3283319a6f","volume":"16","author":"S Paczesny","year":"2009","unstructured":"Paczesny S, Choi SW, Ferrara JL. Acute graft-versus-host disease: new treatment strategies. Curr Opin Hematol. 2009;16(6):427\u201336.","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"581_CR23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbmt.2008.12.001","volume":"15","author":"K Dilger","year":"2009","unstructured":"Dilger K et al. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2009;15(3):336\u201343.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"581_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","volume":"28","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka A et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;28(2):181\u20135.","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"581_CR25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/01.tp.0000296482.50994.1c","volume":"84","author":"S Fuji","year":"2007","unstructured":"Fuji S et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation. 2007;84(7):814\u201320.","journal-title":"Transplantation"},{"issue":"4","key":"581_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bmt.1704596","volume":"34","author":"M Yanada","year":"2004","unstructured":"Yanada M et al. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan. Bone Marrow Transplant. 2004;34(4):331\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"581_CR27","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","volume":"7","author":"F Vincenti","year":"2007","unstructured":"Vincenti F et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant. 2007;7(6):1506\u201314.","journal-title":"Am J Transplant"},{"issue":"12","key":"581_CR28","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1172\/JCI119105","volume":"98","author":"JB Redmon","year":"1996","unstructured":"Redmon JB et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest. 1996;98(12):2786\u201393.","journal-title":"J Clin Invest"},{"issue":"10","key":"581_CR29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.nut.2004.06.003","volume":"20","author":"L Gramlich","year":"2004","unstructured":"Gramlich L et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition. 2004;20(10):843\u20138.","journal-title":"Nutrition"},{"issue":"6","key":"581_CR30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbmt.2006.01.010","volume":"12","author":"PM Sheean","year":"2006","unstructured":"Sheean PM et al. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12(6):656\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"581_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.2006.02437.x","volume":"64","author":"PH Voort der","year":"2006","unstructured":"der Voort PH et al. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf). 2006;64(2):141\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"581_CR32","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jada.2004.06.024","volume":"104","author":"PM Sheean","year":"2004","unstructured":"Sheean PM, Braunschweig C, Rich E. The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: a pilot study. J Am Diet Assoc. 2004;104(9):1352\u201360.","journal-title":"J Am Diet Assoc"},{"issue":"3","key":"581_CR33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.12754","volume":"165","author":"KA Nottage","year":"2014","unstructured":"Nottage KA et al. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia\u2014from the St. Jude Lifetime Cohort. Br J Haematol. 2014;165(3):364\u201374.","journal-title":"Br J Haematol"},{"issue":"12","key":"581_CR34","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.bbmt.2010.05.016","volume":"16","author":"EJ Chow","year":"2010","unstructured":"Chow EJ et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant. 2010;16(12):1674\u201381.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"581_CR35","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.2008.19.7251","volume":"27","author":"KC Oeffinger","year":"2009","unstructured":"Oeffinger KC et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2009;27(22):3698\u2013704.","journal-title":"J Clin Oncol"},{"key":"581_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1748-717X-8-39","volume":"8","author":"AA Siviero-Miachon","year":"2013","unstructured":"Siviero-Miachon AA et al. Cranial radiotherapy predisposes to abdominal adiposity in survivors of childhood acute lymphocytic leukemia. Radiat Oncol. 2013;8:39.","journal-title":"Radiat Oncol"},{"issue":"3","key":"581_CR37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pbc.24308","volume":"60","author":"A Petryk","year":"2013","unstructured":"Petryk A et al. Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors. Pediatr Blood Cancer. 2013;60(3):467\u201373.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"581_CR38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/bmt.2010.307","volume":"46","author":"P Frisk","year":"2011","unstructured":"Frisk P et al. Glucose metabolism and body composition in young adults treated with TBI during childhood. Bone Marrow Transplant. 2011;46(10):1303\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"581_CR39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2265.2004.02149.x","volume":"61","author":"B Bulow","year":"2004","unstructured":"Bulow B et al. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Clin Endocrinol (Oxf). 2004;61(6):683\u201391.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"581_CR40","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(12)70323-6","volume":"13","author":"F Vathaire de","year":"2012","unstructured":"de Vathaire F et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol. 2012;13(10):1002\u201310.","journal-title":"Lancet Oncol"},{"issue":"4","key":"581_CR41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4158\/EP.12.4.358","volume":"12","author":"AC Donihi","year":"2006","unstructured":"Donihi AC et al. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358\u201362.","journal-title":"Endocr Pract"},{"issue":"6","key":"581_CR42","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.3747\/co.20.1499","volume":"20","author":"D Harris","year":"2013","unstructured":"Harris D et al. Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study. Curr Oncol. 2013;20(6):e532\u20138.","journal-title":"Curr Oncol"},{"issue":"6","key":"581_CR43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.20071","volume":"100","author":"MA Weiser","year":"2004","unstructured":"Weiser MA et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone\/methotrexate-cytarabine regimen. Cancer. 2004;100(6):1179\u201385.","journal-title":"Cancer"},{"issue":"1","key":"581_CR44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncr.22777","volume":"110","author":"NA Ali","year":"2007","unstructured":"Ali NA et al. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer. 2007;110(1):96\u2013102.","journal-title":"Cancer"},{"issue":"1","key":"581_CR45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpeds.2009.01.072","volume":"155","author":"RY Sonabend","year":"2009","unstructured":"Sonabend RY et al. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. J Pediatr. 2009;155(1):73\u20138.","journal-title":"J Pediatr"},{"issue":"10","key":"581_CR46","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2337\/dc08-0574","volume":"31","author":"RL Derr","year":"2008","unstructured":"Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care. 2008;31(10):1972\u20137.","journal-title":"Diabetes Care"},{"issue":"3","key":"581_CR47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbmt.2008.12.488","volume":"15","author":"MJ Hammer","year":"2009","unstructured":"Hammer MJ et al. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2009;15(3):344\u201351.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"581_CR48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbmt.2010.07.005","volume":"17","author":"J Pidala","year":"2011","unstructured":"Pidala J et al. Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes. Biol Blood Marrow Transplant. 2011;17(2):239\u201348.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"581_CR49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/COC.0b013e3181e1d0c0","volume":"34","author":"A Brunello","year":"2011","unstructured":"Brunello A, Kapoor R, Extermann M. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. Am J Clin Oncol. 2011;34(3):292\u20136.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"581_CR50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2337\/dc06-2563","volume":"30","author":"R Garg","year":"2007","unstructured":"Garg R et al. Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation. Diabetes Care. 2007;30(4):993\u20134.","journal-title":"Diabetes Care"},{"issue":"6","key":"581_CR51","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pbc.21505","volume":"50","author":"JR Roberson","year":"2008","unstructured":"Roberson JR et al. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(6):1207\u201312.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"581_CR52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/dc09-1748","volume":"33","author":"FJ Pasquel","year":"2010","unstructured":"Pasquel FJ et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33(4):739\u201341.","journal-title":"Diabetes Care"},{"issue":"10","key":"581_CR53","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2337\/diacare.28.10.2367","volume":"28","author":"NW Cheung","year":"2005","unstructured":"Cheung NW et al. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28(10):2367\u201371.","journal-title":"Diabetes Care"},{"issue":"3\u20134","key":"581_CR54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3\u20134):259\u201365.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"581_CR55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clml.2012.05.004","volume":"12","author":"K Vu","year":"2012","unstructured":"Vu K et al. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2012;12(5):355\u201362. This was a randomized controlled trial that compared glargine plus aspart vs. conventional therapy in patients with ALL.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"581_CR56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11892-012-0339-7","volume":"13","author":"D Baldwin","year":"2013","unstructured":"Baldwin D, Apel J. Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes. Curr Diab Rep. 2013;13(1):114\u201320.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"581_CR57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP09102.RA","volume":"15","author":"ES Moghissi","year":"2009","unstructured":"Moghissi ES et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353\u201369.","journal-title":"Endocr Pract"},{"issue":"1","key":"581_CR58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez GE et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16\u201338.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"581_CR59","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3949\/ccjm.78a.10180","volume":"78","author":"MC Lansang","year":"2011","unstructured":"Lansang MC, Hustak LK. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them. Cleve Clin J Med. 2011;78(11):748\u201356.","journal-title":"Cleve Clin J Med"},{"key":"581_CR60","doi-asserted-by":"crossref","unstructured":"Aggarwal N et al. Immeasurable glycosylated haemoglobin: a marker for severe haemolysis. BMJ Case Rep. 2013.","DOI":"10.1136\/bcr-2013-200307"},{"issue":"9\u201310","key":"581_CR61","first-page":"477","volume":"52","author":"D Kutter","year":"2006","unstructured":"Kutter D, Thoma J. Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin. Clin Lab. 2006;52(9\u201310):477\u201381.","journal-title":"Clin Lab"},{"issue":"9","key":"581_CR62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2893.2006.00729.x","volume":"13","author":"PD Greenberg","year":"2006","unstructured":"Greenberg PD et al. Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. J Viral Hepat. 2006;13(9):613\u20137.","journal-title":"J Viral Hepat"},{"issue":"Pt 5","key":"581_CR63","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1258\/acb.2011.010121","volume":"48","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y et al. A patient with acute lymphoblastic leukaemia presenting with an extremely high level (21.0%) of HbA(1c). Ann Clin Biochem. 2011;48(Pt 5):474\u20137.","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"581_CR64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/dc11-1321","volume":"35","author":"PS Hardikar","year":"2012","unstructured":"Hardikar PS et al. Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young Indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care. 2012;35(4):797\u2013802.","journal-title":"Diabetes Care"},{"issue":"4","key":"581_CR65","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc09-0836","volume":"33","author":"C Kim","year":"2010","unstructured":"Kim C et al. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010;33(4):780\u20135.","journal-title":"Diabetes Care"},{"issue":"9","key":"581_CR66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dia.2012.0192","volume":"14","author":"KM Dungan","year":"2012","unstructured":"Dungan KM. Predicting outcomes and assessing control with alternate glycemic markers. Diabetes Technol Ther. 2012;14(9):749\u201352.","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"581_CR67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1797.2011.01517.x","volume":"17","author":"FE Vos","year":"2012","unstructured":"Vos FE et al. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton). 2012;17(2):182\u20138.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"581_CR68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4158\/EP12256.OR","volume":"19","author":"AR Gosmanov","year":"2013","unstructured":"Gosmanov AR et al. Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy. Endocr Pract. 2013;19(2):231\u20135. This is the first study comparing basal\/bolus insulin and sliding scale insulin in diabetic patients with hematologic malignancies treated with dexamethasone.","journal-title":"Endocr Pract"},{"issue":"2","key":"581_CR69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3810\/hp.2014.04.1100","volume":"42","author":"EK Spanakis","year":"2014","unstructured":"Spanakis EK et al. Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemia. Hosp Pract (1995). 2014;42(2):23\u201330.","journal-title":"Hosp Pract (1995)"},{"issue":"5","key":"581_CR70","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4158\/EP11371.OR","volume":"18","author":"SM Dhital","year":"2012","unstructured":"Dhital SM et al. A retrospective study comparing neutral protamine hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients. Endocr Pract. 2012;18(5):712\u20139. This study in hospitalized patients receiving prednisone demonstrated that NPH and glargine appeared equally effective.","journal-title":"Endocr Pract"},{"issue":"4","key":"581_CR71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2337\/dc08-1436","volume":"32","author":"MT Korytkowski","year":"2009","unstructured":"Korytkowski MT et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009;32(4):594\u20136.","journal-title":"Diabetes Care"},{"issue":"6","key":"581_CR72","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0148607104028006447","volume":"28","author":"PR Schloerb","year":"2004","unstructured":"Schloerb PR. Glucose in parenteral nutrition: a survey of U.S. medical centers. JPEN J Parenter Enteral Nutr. 2004;28(6):447\u201352.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"581_CR73","unstructured":"Baldwin D et al. Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN). In: American Diabetes Association 72nd Scientific Sessions. Philadelphia, PA; 2012. p. #1070-P."},{"issue":"3","key":"581_CR74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-13-0610","volume":"170","author":"RE Genugten van","year":"2014","unstructured":"van Genugten RE et al. Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial. Eur J Endocrinol. 2014;170(3):429\u201339. This was a double-blind randomized-controlled study investigating DPP4 inhibition in patients with metabolic syndrome receiving high dose prednisolone.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"581_CR75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc10-1677","volume":"34","author":"DH Raalte van","year":"2011","unstructured":"van Raalte DH et al. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011;34(2):412\u20137. This randomized, placebo-controlled, double-blind, crossover study showed that glucagon-like peptide receptor agonist exenatide prevented glucocorticoid-induced glucose intolerance.","journal-title":"Diabetes Care"},{"issue":"4","key":"581_CR76","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc9101","volume":"14","author":"I Gornik","year":"2010","unstructured":"Gornik I et al. A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes. Crit Care. 2010;14(4):R130.","journal-title":"Crit Care"},{"issue":"10 Suppl","key":"581_CR77","first-page":"Ss3","volume":"75","author":"J Davidson","year":"2003","unstructured":"Davidson J et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75(10 Suppl):Ss3\u201324.","journal-title":"Transplantation"},{"issue":"3","key":"581_CR78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0012.2005.00359.x","volume":"19","author":"A Wilkinson","year":"2005","unstructured":"Wilkinson A et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant. 2005;19(3):291\u20138.","journal-title":"Clin Transplant"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-015-0581-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-015-0581-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-015-0581-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T12:26:41Z","timestamp":1566304001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-015-0581-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1007\/s11892-015-0581-x","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]},"article-number":"8"}}